课题基金 / 基金详情

A STUDY ON CLASSIFICATION OF ANTIPSYCHOTIC DRUGS BY MEANS OF THEIR ABILITY TO INDUCE THE RELEASE OF NEUROTRANSMITTERS

A STUDY ON CLASSIFICATION OF ANTIPSYCHOTIC DRUGS BY MEANS OF THEIR ABILITY TO INDUCE THE RELEASE OF NEUROTRANSMITTERS
根据抗精神病药物诱导神经递质释放的能力进行分类的研究
批准号:
11670949
负责人:
KUROKI Toshihide
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

KUROKI Toshihide的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. We established the in vivo method of monitoring in real-time extracellular glutamate levels in rat medial prefrontal cortex by employing the microdialysis technique and then examined the effect of different types of antipsychoic drugs on prefrontal glutamate release. The atypical antipsychotic drugs such as clozapine, olanzapine and risperidone at at least one dose, but not the typical antipsychotic haloperidol, attenuated high K^+-induced extracellular glutamate levels in the medial prefrontal cortex. This finding suggests that acute administration of atypical antipsychotics may inhibit prefrontal glutamatergic activity.2. Since atypical antipsychotic drugs selectively attenuated the expression of the immediate-early gene arc in the medial prefrontal cortex and nucleus accumbens of phencyclidine-treated rats, this animal model of schizophrenia may be useful for elucidating the sites of action of these drugs. However, alteration of dopaminergic neurotransmission may not contribute t … More o the mechanism of action of atypical antipsychotic drugs in regard to their ability to attenuate phencyclidine-induced arc expression.3. Taken together with previous reports from other laboratories, acute administration of clozapine, risperidone and olanzapine may increase the release of dopamine, norepinephrine and acetylcholine in rat prefrontal cortex. These atypical antipsychotics may decrease prefrontal glutamate release at at least one dose, whereas risperidone, but not clozapine or olanzapine, may facilitate serotonin release. Haloperidol may have minimal effect on the prefrontal release of either neurotransmitters.4. By means of the ability to induce the region-specific release of dopamine, norepinephrine and acetylcholine, antipsychotic drugs may be classified into three types: I. dominantly prefrontal type such as clozapine, II. Non-dominantly prefrontal type such as risperidone, and III. Dominantly subcortical type such as haloperidol. The former two types are atypical antipsychotics in regard to the clinical effects, although the type II drugs at high doses lack their atypicality. Less
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Kuroki,T.et al.: "Effects of antipsychotic drugs on extracellular dopamine levels in prefrontal cortex and nucleus accumbens"Journal of Pharmacology & Experimental Therapeutics. 288・2. 774-781 (1999)
Kuroki,T.等人:“抗精神病药物对前额皮质和伏隔核细胞外多巴胺水平的影响”《药理学与实验治疗学杂志》288・2(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuroki,T. et al.: "R(+)-OH-DPAT, a selective 5-HT_<1A> receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex."Brain Research. 872巻. 204-207 (2000)
Kuroki, T. 等人:“R(+)-OH-DPAT,一种选择性 5-HT_1A 受体激动剂,可减弱安非他明诱导的大鼠纹状体中的多巴胺合成,但不会减弱伏隔核或内侧前额皮质。”研究。第 872 卷。204-207 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
黒木俊秀,田代信維: "賦活・抗うつ作用を発揮する抗精神病薬スルピリドとリスペリドンの薬理."Pharma Medica. 18巻. 149-157 (2000)
Toshihide Kuroki、Nobuyoshi Tashiro:“具有激活和抗抑郁作用的抗精神病药物舒必利和利培酮的药理学”,Pharma Medica,第 18 卷,149-157 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
黒木俊秀: "非定型抗精神病薬の作用機序における前頭前野皮質グルタミン酸系-セロトニン系機能連関の解明"精神薬療研究年報. 34(印刷中). (2002)
Toshihide Kuroki:“阐明非典型抗精神病药作用机制中前额皮质中谷氨酸系统和血清素系统之间的功能关系”,《精神药理学治疗年度报告》34(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    The validity and utility of the DSM diagnosis for psychological assessment: an empirical study
    • 批准号:
      17K04423
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2017
    • 负责人:
      KUROKI Toshihide
    • 依托单位:
    Study on the pharmacological basis for the effect of psychological stress in the early life stage on response to psychotropic drugs
    • 批准号:
      17591219
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.25万
    • 财政年份:
      2005
    • 负责人:
      KUROKI Toshihide
    • 依托单位:
    海外基金